NO20003960D0 - Salts of paroxetine - Google Patents
Salts of paroxetineInfo
- Publication number
- NO20003960D0 NO20003960D0 NO20003960A NO20003960A NO20003960D0 NO 20003960 D0 NO20003960 D0 NO 20003960D0 NO 20003960 A NO20003960 A NO 20003960A NO 20003960 A NO20003960 A NO 20003960A NO 20003960 D0 NO20003960 D0 NO 20003960D0
- Authority
- NO
- Norway
- Prior art keywords
- paroxetine
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (34)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9802640.4A GB9802640D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802664.4A GB9802664D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802645.3A GB9802645D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802644.6A GB9802644D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802698.2A GB9802698D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802646.1A GB9802646D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802659.4A GB9802659D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802665.1A GB9802665D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802638.8A GB9802638D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802653.7A GB9802653D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802656.0A GB9802656D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802654.5A GB9802654D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802639.6A GB9802639D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802655.2A GB9802655D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802657.8A GB9802657D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802658.6A GB9802658D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802661.0A GB9802661D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9817340.4A GB9817340D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817317.2A GB9817317D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817321.4A GB9817321D0 (en) | 1998-08-08 | 1998-08-08 | Novel compound |
GBGB9817359.4A GB9817359D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817307.3A GB9817307D0 (en) | 1998-08-08 | 1998-08-08 | Novel compound |
GBGB9817344.6A GB9817344D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817309.9A GB9817309D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817360.2A GB9817360D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817364.4A GB9817364D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817322.2A GB9817322D0 (en) | 1998-08-10 | 1998-08-10 | Novel compounds |
GBGB9817320.6A GB9817320D0 (en) | 1998-08-10 | 1998-08-10 | Novel compounds |
GBGB9826172.0A GB9826172D0 (en) | 1998-11-30 | 1998-11-30 | Novel compound |
GBGB9826173.8A GB9826173D0 (en) | 1998-11-30 | 1998-11-30 | Novel compounds |
GBGB9827341.0A GB9827341D0 (en) | 1998-12-11 | 1998-12-11 | Novel compounds |
GBGB9827277.6A GB9827277D0 (en) | 1998-12-11 | 1998-12-11 | Novel compound |
GBGB9828775.8A GB9828775D0 (en) | 1998-12-29 | 1998-12-29 | Novel compounds |
PCT/GB1999/000380 WO1999040084A1 (en) | 1998-02-06 | 1999-02-05 | Salts of paroxetine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003960D0 true NO20003960D0 (en) | 2000-08-04 |
NO20003960L NO20003960L (en) | 2000-09-25 |
Family
ID=27586915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003960A NO20003960L (en) | 1998-02-06 | 2000-08-04 | Salts of paroxsetine |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1053234A1 (en) |
JP (1) | JP2002505254A (en) |
KR (1) | KR20010040711A (en) |
BG (1) | BG104737A (en) |
CA (1) | CA2319652A1 (en) |
EA (1) | EA200000815A1 (en) |
IL (1) | IL137684A0 (en) |
NO (1) | NO20003960L (en) |
PL (1) | PL342295A1 (en) |
SK (1) | SK11812000A3 (en) |
WO (1) | WO1999040084A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH689805A8 (en) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it. |
GB9814316D0 (en) * | 1998-07-02 | 1998-09-02 | Smithkline Beecham Plc | Novel compounds |
WO2000008016A1 (en) * | 1998-08-08 | 2000-02-17 | Smithkline Beecham Plc | Paroxetine salts |
GB9827431D0 (en) * | 1998-12-11 | 1999-02-03 | Smithkline Beecham Plc | Novel compound |
AU5078700A (en) * | 1999-06-22 | 2001-01-09 | Smithkline Beecham Plc | Novel composition |
HU226912B1 (en) * | 2000-04-07 | 2010-03-01 | Richter Gedeon Nyrt | New paroxetin salt and medicament containing it |
CN1484642A (en) * | 2001-01-05 | 2004-03-24 | Excitatory amino acid receptor antagonists | |
CA2456233A1 (en) * | 2001-08-02 | 2003-03-13 | Spurcourt Limited | Paroxetine isethionate salt, process of preparation and use in the treatment of depression |
KR100672184B1 (en) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | Paroxetine cholate or cholic acid derivative salts |
CN108218844B (en) * | 2018-03-08 | 2021-01-19 | 合肥科大生物技术有限公司 | Memantine paroxetine eutectic salt and preparation method, pharmaceutical composition and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
HU221921B1 (en) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them |
-
1999
- 1999-02-05 SK SK1181-2000A patent/SK11812000A3/en unknown
- 1999-02-05 EA EA200000815A patent/EA200000815A1/en unknown
- 1999-02-05 PL PL99342295A patent/PL342295A1/en not_active Application Discontinuation
- 1999-02-05 WO PCT/GB1999/000380 patent/WO1999040084A1/en not_active Application Discontinuation
- 1999-02-05 KR KR1020007008591A patent/KR20010040711A/en not_active Application Discontinuation
- 1999-02-05 CA CA002319652A patent/CA2319652A1/en not_active Abandoned
- 1999-02-05 IL IL13768499A patent/IL137684A0/en unknown
- 1999-02-05 JP JP2000530513A patent/JP2002505254A/en active Pending
- 1999-02-05 EP EP99904971A patent/EP1053234A1/en not_active Withdrawn
-
2000
- 2000-08-04 NO NO20003960A patent/NO20003960L/en not_active Application Discontinuation
- 2000-08-30 BG BG104737A patent/BG104737A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20003960L (en) | 2000-09-25 |
EA200000815A1 (en) | 2001-02-26 |
EP1053234A1 (en) | 2000-11-22 |
BG104737A (en) | 2001-07-31 |
JP2002505254A (en) | 2002-02-19 |
SK11812000A3 (en) | 2001-08-06 |
IL137684A0 (en) | 2001-10-31 |
WO1999040084A1 (en) | 1999-08-12 |
CA2319652A1 (en) | 1999-08-12 |
KR20010040711A (en) | 2001-05-15 |
PL342295A1 (en) | 2001-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2014027I1 (en) | USE OF DIALKYLO FUMARIC ESTERS | |
ID27092A (en) | MAKING OF ANHYDRIDAL FTALATES | |
IS2277B (en) | Therapeutic baryl derivatives | |
PT1089996E (en) | PAROXETINE METHOSULPHONATE | |
EE200300007A (en) | Heterocyclic derivatives of tetrahydropyridine or piperidine | |
FR2780269B1 (en) | RACHIDIAN IMPLANT | |
NO20011083L (en) | Crystalline forms of EtOC2 - CH2 - (R) Cgl-Aze-Pab-OH | |
NO20003960D0 (en) | Salts of paroxetine | |
PT1246817E (en) | DERIVATIVES OF 4-PHENYL-1-PIPERAZINYL, -PIPERIDINYL E-TETRAHYDROPYRIDYL | |
NO20006547D0 (en) | Salts of paroxetine | |
NO20016151D0 (en) | Preparation of substituted piperidin-4-ones | |
ID28032A (en) | TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2 | |
NO20010553L (en) | Crystalline forms of osanetant | |
FI980222A0 (en) | Stycke av isoleringsaemne med en genomgaoende primaerstroemledning | |
DE50009938D1 (en) | USE OF NANOSCALE GROWTH | |
EE200100381A (en) | New salts of morpholinobenzamide | |
EE200100017A (en) | New salts of N-tert-butylhydroxylamine | |
FR2802852B3 (en) | PRODUCTION OF FIGURE ELEMENTS | |
PT1178984E (en) | DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMIMOME | |
PT1175417E (en) | SUBSTITUTED COMPOUNDS OF BENZOLACTAMAS | |
NO20004583D0 (en) | Crystalline form of paroxetine | |
FI981803A0 (en) | Method for preventing the formation of precipitates | |
NO20016030D0 (en) | Derivatives of 4'-demycarosyl-8a-aza-8a-homothylosin | |
PT1232141E (en) | ETERIES OF O-DESMETIL-VENLAFAXIN | |
NO20005683D0 (en) | New formulation containing paroxetine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |